Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acetylation.

W W Weber1

  • 1Department of Toxicology, University of Michigan Medical School, Ann Arbor 48109.

Birth Defects Original Article Series
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

The human acetylation polymorphism, affecting drug metabolism, classifies individuals as slow or rapid acetylators based on N-acetyltransferase enzyme activity. Understanding this trait is crucial for predicting drug responses and toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacogenetic tactics and strategies: implications for paediatrics.

Paediatric drugs·2002
Same author

The legacy of pharmacogenetics and potential applications.

Mutation research·2001
Same author

Effect of pharmacogenetics on medicine.

Environmental and molecular mutagenesis·2001
Same author

Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber.

Drug metabolism and disposition: the biological fate of chemicals·2000
Same author

Characterization of naturally occurring and recombinant human N-acetyltransferase variants encoded by NAT1.

Molecular pharmacology·2000
Same author

Populations and genetic polymorphisms.

Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology·2000
Same journal

A case of short-rib syndrome without polydactyly in a stillborn: a new type?

Birth defects original article series·1996
Same journal

Hand malformations in the aborted embryo: an important source of genetic information.

Birth defects original article series·1996
Same journal

Colophon: on doing morphology.

Birth defects original article series·1996
Same journal

Congenital eye malformations: a descriptive epidemiologic study in about one million newborns in Italy.

Birth defects original article series·1996
Same journal

CHARGE association in a neonate exposed in utero to carbon monoxide.

Birth defects original article series·1996
Same journal

Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.

Birth defects original article series·1996
See all related articles

Area of Science:

  • Pharmacogenetics
  • Human Genetics
  • Drug Metabolism

Background:

  • The human acetylation polymorphism, discovered over 30 years ago, influences the metabolism of numerous drugs, particularly hydrazine and arylamine compounds.
  • Individuals are phenotyped as either 'slow' or 'rapid' acetylators, determined by the activity of N-acetyltransferase (NAT) enzymes in various tissues.

Purpose of the Study:

  • To investigate the genetic basis and clinical implications of the human acetylation polymorphism.
  • To highlight the importance of acetylator status in predicting individual drug responses and toxicities.

Main Methods:

  • Phenotyping individuals as slow or rapid acetylators using various test agents like caffeine, isoniazid, sulfamethazine, and sulfapyridine.
  • Investigating the genetic linkage of the N-acetyltransferase gene in animal models.

Related Experiment Videos

Main Results:

  • The acetylator phenotype is a stable, lifelong characteristic influenced by N-acetyltransferase enzyme activity.
  • Caffeine serves as a versatile test agent, distinguishing between slow, homozygous rapid, and heterozygous rapid acetylators.

Conclusions:

  • Acetylator status provides valuable insights into therapeutic, pharmacologic, and toxicologic responses to commonly used drugs.
  • Further research is recommended to determine the chromosomal locus of human acetylator genes and develop advanced molecular diagnostic tests.